- Home
- AGX vs XENE Comparison
AGX vs XENE Comparison
Compare AGX & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGX
- XENE
- Stock Information
- Founded
- AGX 1961
- XENE 1996
- Country
- AGX United States
- XENE Canada
- Employees
- AGX N/A
- XENE N/A
- Industry
- AGX Engineering & Construction
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- AGX Consumer Discretionary
- XENE Health Care
- Exchange
- AGX Nasdaq
- XENE Nasdaq
- Market Cap
- AGX 3.0B
- XENE 2.4B
- IPO Year
- AGX N/A
- XENE 2014
- Fundamental
- Price
- AGX $235.73
- XENE $30.30
- Analyst Decision
- AGX Buy
- XENE Strong Buy
- Analyst Count
- AGX 3
- XENE 11
- Target Price
- AGX $202.00
- XENE $54.82
- AVG Volume (30 Days)
- AGX 422.8K
- XENE 1.4M
- Earning Date
- AGX 09-04-2025
- XENE 08-07-2025
- Dividend Yield
- AGX 0.64%
- XENE N/A
- EPS Growth
- AGX 154.06
- XENE N/A
- EPS
- AGX 7.14
- XENE N/A
- Revenue
- AGX $910,157,000.00
- XENE $7,500,000.00
- Revenue This Year
- AGX $10.87
- XENE N/A
- Revenue Next Year
- AGX $18.35
- XENE $253.71
- P/E Ratio
- AGX $33.02
- XENE N/A
- Revenue Growth
- AGX 45.08
- XENE N/A
- 52 Week Low
- AGX $63.53
- XENE $26.74
- 52 Week High
- AGX $246.60
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- AGX 65.28
- XENE 39.19
- Support Level
- AGX $196.90
- XENE $30.84
- Resistance Level
- AGX $228.04
- XENE $32.72
- Average True Range (ATR)
- AGX 10.95
- XENE 1.07
- MACD
- AGX 1.56
- XENE -0.19
- Stochastic Oscillator
- AGX 90.32
- XENE 1.98
About AGX Argan Inc.
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.